These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8585031)

  • 1. High level of plasmatic von Willebrand factor limits the bleeding time in thrombopenic HIV-infected patients.
    Guérin V; Morlat P; Chêne G; Grobost F; Aubertin J; Boisseau M
    Thromb Haemost; 1995 Aug; 74(2):803-4. PubMed ID: 8585031
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble P-selectin, thrombocytopenia and von Willebrand factor in HIV infected patients.
    Blann AD; Seigneur M; Constans J; Pellegrin JL; Conri C
    Thromb Haemost; 1997 Jun; 77(6):1221-2. PubMed ID: 9241764
    [No Abstract]   [Full Text] [Related]  

  • 3. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding time and concentrations of von Willebrand factor in patients with acute upper gastrointestinal bleeding.
    Henriksson AE; Nilsson TK; Bergavist D
    Eur J Surg; 1996 Aug; 162(8):627-31. PubMed ID: 8891620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV-related thrombocytopenias].
    Mannucci PM; Gringeri A
    Ann Ital Med Int; 2000; 15(1):20-7. PubMed ID: 10842888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intermittent thrombocytopenia as a manifestation of Von Willebrand's disease].
    Gómez García EB; Brouwers GJ; Kappers-Klunne MC; Leebeek FW; van Vliet HH
    Ned Tijdschr Geneeskd; 2002 Jun; 146(25):1192-5. PubMed ID: 12109311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in hemostasis in chronic renal insufficiency].
    Lozano Arce T
    Med Clin (Barc); 1988 Apr; 90(15):620-2. PubMed ID: 3294531
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of inherited von Willebrand disease.
    Mannucci PM; Federici AB
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):455-62. PubMed ID: 11686109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
    Wang L; Li Y; Hou M
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic thrombocytopaenic purpura in HIV-infected patients.
    Miller RF; Scully M; Cohen H; Roedling S; Starke R; Edwards SG; Machin SJ
    Int J STD AIDS; 2005 Aug; 16(8):538-42. PubMed ID: 16105187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of thrombopoietin level measurements in thrombocytopenia.
    Porcelijn L; Folman CC; Bossers B; Huiskes E; Overbeeke MA; v d Schoot CE; de Haas M; von dem Borne AE
    Thromb Haemost; 1998 Jun; 79(6):1101-5. PubMed ID: 9657431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.
    Wang ZJ; Onwuzurike N; Callaghan MU; Rajpurkar M; Chitlur M; Lusher JM
    Pediatr Blood Cancer; 2008 Sep; 51(3):416-8. PubMed ID: 18493997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating thrombopoietin and interleukin-6 in newly diagnosed autoimmune versus aplastic thrombocytopenia.
    Koşar A; Haznedaroglu IC; Büyükaşik Y; Ozcebe O; Kírazli S; Dündar S
    Haematologica; 1998 Nov; 83(11):1055-6. PubMed ID: 9864934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of thrombopoietin in the diagnosis of peripheral thrombocytopenias.
    Español I; Hernández A; Muñiz-Diaz E; Ayats R; Pujol-Moix N
    Haematologica; 1999 Jul; 84(7):608-13. PubMed ID: 10406902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic thrombocytopenic purpura: a rare cause of thrombocytopenia in HIV-infected hemophiliacs.
    Ahmed S; Sadiq A; Siddiqui AK; Lipton RA; Mattana J
    Ann Hematol; 2004 Apr; 83(4):253-5. PubMed ID: 14513287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand's syndrome: a single institution experience.
    Kumar S; Pruthi RK; Nichols WL
    Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment: raised soluble P selectin and the risk of thrombosis in HIV-1 infection.
    Blann A
    Thromb Haemost; 2002 Dec; 88(6):1078. PubMed ID: 12529770
    [No Abstract]   [Full Text] [Related]  

  • 20. [High-shear force-induced platelet aggregation in the screening and diagnosis of von Willebrand disease].
    Schlammadinger A; Kerényi A; Muszbek L; Boda Z
    Orv Hetil; 2000 Oct; 141(41):2245-50. PubMed ID: 11184249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.